Restriction of dietary salt to alleviate or prevent volume overload in patients with acute decompensated heart failure (ADHF) is common hospital practice, but without a solid evidence base. A trial ...
A multicenter study has identified a potential new treatment for acute heart failure, a leading cause of hospitalization and death. A multicenter study led by Vanderbilt University Medical Center ...
Nonpharmacologic heart failure management and interventions can reduce cardiovascular risk factors and carotid intima-media ...
This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Michelle M.
Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...
Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...
Empagliflozin stabilizes kidney function and reduces heart failure risk post-myocardial infarction, with eGFR remaining stable over 24 months. The EMPACT-MI trial confirmed empagliflozin's safety when ...
Decompensated heart failure (DHF) means that symptoms from heart failure are severe enough to require immediate medical attention. Dyspnea or shortness of breath is the most common symptom of DHF.
Windtree Therapeutics, Inc. announced progress in its research on istaroxime and a selective SERCA2a activator, demonstrating a reduction in arrhythmias in an animal study, which will be presented at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results